Form 4: Abeona Therapeutics Director Faith L. Charles Reports Acquisition of Common Stock

Director Faith L. Charles reports acquisition of 11,797 shares of Abeona Therapeutics common stock as part of the 2024 annual grant to the board of directors.

Summary

• On August 26, 2024, Faith L. Charles, a director of Abeona Therapeutics Inc., acquired 11,797 shares of common stock.
• The acquisition was part of the 2024 annual grant to the board of directors and was exempt pursuant to Rule 16b-3(d).
• The stock grant was withheld until all employees/management were allocated their shares and to enable onboarding of two new Board members.
• The price per share was $0.
• Following the transaction, Charles directly owns 113,731 shares of Abeona Therapeutics Inc.
• The restricted stock will vest on August 26, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, indicating confidence in the company. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director signals confidence in the company's future.
• The stock grant serves as an incentive for board members.

Future Outlook

The restricted stock will vest on August 26, 2025.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the ownership changes of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The stock grant aligns the interests of the director with those of the shareholders.

Key Dates